Back to User profile » Dr Christopher Compton
Papers published by Dr Christopher Compton:
Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England
Requena G, Banks V, Czira A, Wood R, Tritton T, Wild R, Compton C, Duarte M, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1781-1795
Published Date: 10 August 2022
Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England
Rothnie KJ, Joksaite S, Sansbury LB, Compton C, Di Boscio V, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1455-1466
Published Date: 22 June 2022
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model
Shukla S, Shah D, Martin A, Risebrough NA, Kendall R, Vogelmeier CF, Boucot I, Tombs L, Bjermer L, Jones PW, Kerwin E, Compton C, Maltais F, Lipson DA, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3105-3118
Published Date: 13 November 2021
Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England
Sansbury LB, Rothnie KJ, Bains C, Compton C, Anley G, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2591-2604
Published Date: 15 September 2021
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial
Bjermer L, Boucot IH, Maltais F, Kerwin EM, Naya IP, Tombs L, Jones PW, Compton C, Lipson DA, Vogelmeier CF
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1939-1956
Published Date: 28 June 2021
A Prospective Cohort Study to Assess Obstructive Respiratory Disease Phenotypes and Endotypes in Japan: The TRAIT Study Design
Hizawa N, Fukunaga K, Sugiura H, Nakano Y, Kato M, Sugiyama Y, Hanazawa T, Kaise T, Tal-Singer R, Jones PW, Barnes N, Compton C, Ishii T
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1813-1822
Published Date: 18 June 2021
Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement
Vogelmeier CF, Naya IP, Maltais F, Bjermer L, Kerwin EM, Tombs L, Jones PW, Compton C, Lipson DA, Boucot IH
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1215-1226
Published Date: 3 May 2021
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
Bourbeau J, Bafadhel M, Barnes NC, Compton C, Di Boscio V, Lipson DA, Jones PW, Martin N, Weiss G, Halpin DMG
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:499-517
Published Date: 1 March 2021
Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting
Whittaker HR, Müllerova H, Jarvis D, Barnes NC, Jones PW, Compton CH, Kiddle SJ, Quint JK
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1063-1073
Published Date: 23 May 2019